The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current ...

Beam Therapeutics (NasdaqGS:BEAM) was named one of TIME’s 10 Most Influential Health & Life Science Companies of 2026. The recognition highlights Beam’s progress in base editing gene therapies and its ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the disease could be tackled at its genetic root, ...

In late April 2026, analysts highlighted expectations for higher year-over-year earnings and revenue at CRISPR Therapeutics ahead of its March-quarter report, alongside strong launch metrics for ...

From cancer-targeting enzymes to AI-designed editors, CRISPR technology is rapidly evolving into safer, more precise tools for research and therapy. Innovations like ThermoCas9, chromosome silencing ...

A year after Baby KJ became the first person to receive a personalized CRISPR base-editing therapy for a lethal genetic disorder, he is thriving and has avoided a liver transplant. His case, enabled ...

Sweet maize is often referred to as the 'King of fruits and vegetables' due to its richness in polysaccharides, dietary fiber, trace elements, vitamins, linoleic acid, and other essential nutrients.

Genome editing is revolutionizing the medical landscape by offering new therapeutic possibilities for genetic diseases, which collectively affect hundreds ...